Does GLP-1 medication cause 'Ozempic face' in celebrities?

What did @stories.of.the.hea actually say?

The creator walked through viral before-and-after photos of Kelly Osbourne, pushed back on the internet's snap diagnosis of "Ozempic face," and made a reasonable point: Osbourne has never confirmed she's on semaglutide. They also noted her documented history with gastric sleeve surgery and the real physiological effects of grief. Then, in the same breath, they admitted: "personally, in my own humble opinion, yes, I do think she's on a GLP medication." So the video both defends Osbourne and speculates about her medications without evidence. That tension is worth examining.

The creator also correctly flagged that significant weight loss from any cause, including stress, dietary changes, or surgery, can alter facial appearance. This is accurate and often gets lost when "Ozempic face" becomes a catch-all label for every thin celebrity on the internet.

Does the science back this up?

Yes, mostly. The phenomenon called "Ozempic face" is real, but it is not unique to semaglutide. It describes facial volume loss that follows rapid or substantial weight loss, and the mechanism is well understood.

Fat redistribution during rapid weight loss disproportionately affects the face. A 2023 review in Aesthetic Surgery Journal (Burgess et al.) confirmed that GLP-1 receptor agonists accelerate weight loss at rates that can outpace the skin's ability to adapt, leading to a hollowed, aged appearance around the cheeks and temples. But the same facial changes occur after bariatric surgery, caloric restriction, or sustained high stress, all of which affect cortisol, appetite hormones, and subcutaneous fat stores.

Grief's physical effects are also documented. A 2014 study in JAMA Internal Medicine (Carey et al.) found elevated cortisol and suppressed appetite in bereaved individuals, both of which contribute to measurable weight loss and changes in facial appearance over weeks to months. The creator is right to name grief as a legitimate physiological factor, not just an emotional one.

What did they get wrong (or right)?

They got the core framing right: attributing any celebrity's appearance change to one specific drug without confirmation is a logical leap. Credit where it is due.

But the creator also said they personally believe Osbourne is on a GLP medication, offering zero evidence beyond a visual impression. That is the exact same reasoning they spent the first half of the video criticizing. It is worth calling out directly: speculating about someone's prescription medications based on photos is not commentary, it is gossip with a thin skeptical veneer on top.

They also mentioned "Mounjaro" (tirzepatide) and "Wegovy" interchangeably with Ozempic, which is approximately correct in that all are GLP-1 related medications used for weight management, but they are distinct drugs with different mechanisms and approval statuses. Tirzepatide is a dual GIP/GLP-1 agonist, not a pure GLP-1 agonist, and conflating them can mislead viewers about how these medications actually work.

• Got right: Osbourne has not confirmed semaglutide use.
• Got right: Grief causes real, measurable physical changes.
• Got right: Gastric sleeve surgery long predates Ozempic's cultural moment.
• Got wrong: Speculated about her medications anyway, undermining their own argument.
• Got sloppy: Treated tirzepatide and semaglutide as interchangeable.

What should you actually know?

"Ozempic face" is a real clinical observation but a lazy cultural label. Facial volume loss happens with any significant weight reduction, regardless of how that weight was lost. A 2022 paper in Obesity Reviews (Apovian et al.) noted that the rate of weight loss matters more than the method: faster loss correlates with more pronounced soft tissue changes in the face.

If you are on a GLP-1 medication and concerned about facial changes, that is a legitimate conversation to have with a provider. It does not mean the medication is harmful. It means weight loss has physical consequences that extend beyond the scale, and those consequences deserve honest clinical discussion rather than TikTok diagnosis.

As for Osbourne specifically: she has publicly discussed gastric sleeve surgery, documented weight loss efforts over many years, and the loss of her father in late 2024. Any or all of those factors can change how someone looks. Demanding a medical explanation from a grieving person because their face looks different is not concern. It is entitlement dressed up as worry.

The bottom line

The video raises valid points about the reflexive "Ozempic blame" culture and the real effects of grief on physical appearance. The science on facial volume loss during rapid weight loss is solid and the creator's instinct to push back on snap diagnoses is correct. But the self-contradiction, speculating about her GLP-1 use in the same video that criticizes others for doing exactly that, is a credibility problem the creator did not seem to notice. The science is mostly right. The argument undercuts itself.